Home » Topics » BioWorld Science

BioWorld Science
RSS

Ficolin binding inhibitors patented by Osaka University

May 25, 2018

Sichuan Kelun-Biotech Biopharmaceutical presents antiviral compounds

May 25, 2018

European designation decisions for BioCryst's BCX-7353 for HAE

May 25, 2018

CLCF1 biomarker may help diagnose delayed graft function in kidney transplantation

May 25, 2018

Vanderbilt University discovers muscarinic acetylcholine M4 receptor positive allosteric modulators

May 25, 2018

Takeda describes metabotropic glutamate mGlu7 receptor agonists

May 25, 2018

FDA accepts NDA resubmission for Dsuvia

May 25, 2018

Phase III study of Arzerra plus bendamustine in indolent NHL did not meet primary endpoint

May 25, 2018

New NTRK1 inhibitors discovered at Shionogi

May 25, 2018

Chugai seeks Japanese approval for Actemra for adult-onset Still's disease

May 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...